Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELE | P16581 | 1/20 | 0.33 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.31 |
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12314779 | 0.95 | SELE (0.33) | SELEVCAM1ALDH1A1MAPTL3MBTL1 | |
| SCHEMBL15276697 | 0.92 | — | — | |
| SCHEMBL11892862 | 0.90 | LMNA (0.31) | — | |
| SCHEMBL12336836 | 0.87 | — | — | |
| SCHEMBL12651752 | 0.85 | LMNA (0.31) | ALDH1A1MAPTL3MBTL1 | |
| SCHEMBL18874433 | 0.78 | — | — | |
| SCHEMBL10062429 | 0.77 | PKM (0.30) | — | |
| SCHEMBL13021047 | 0.77 | — | — | |
| SCHEMBL13467108 | 0.74 | ERCC5 (0.33) | ALDH1A1MAPTCYP1A2CYP2C9TSHR | |
| SCHEMBL12567048 | 0.71 | PKM (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8389670-B2 | Dithienobenzo-thieno[3,2-B]thiophene-copolymer and its use as high performance solution processable semiconducting polymer | BASF SE (DE) | 2013-03-05 | — | — | US | disclosed |
| US-8334456-B2 | Conjugated polymers and their use in optoelectronic devices | POLYERA CORPORATION (US) | 2012-12-18 | — | — | US | disclosed |
| US-8329855-B2 | Thienocoronene-imide semiconducting compounds and polymers | POLYERA CORPORATION (US) | 2012-12-11 | — | — | US | disclosed |
| US-20120264900-A1 | THIENOCORONENE-IMIDE SEMICONDUCTING COMPOUNDS AND POLYMERS | USINVEST LLC | 2012-10-18 | — | — | US | disclosed |
| US-20120227812-A1 | NAPHTHOBISTHIADIAZOLE POLYMERS FOR USE IN ORGANIC SEMICONDUCTOR DEVICES | RAYNERGY TEK INC. (TW) | 2012-09-13 | — | — | US | disclosed |
| US-20120217482-A1 | SEMICONDUCTOR MATERIALS PREPARED FROM DITHIENYLVINYLENE COPOLYMERS | POLYERA CORPORATION (US) | 2012-08-30 | — | — | US | disclosed |
| US-20120187385-A1 | Conjugated Polymers and Their Use in Optoelectronic Devices | RAYNERGY TEK INC. (TW) | 2012-07-26 | — | — | US | disclosed |
| US-20110213117-A1 | Organic Semiconducting Polymers | POLYERA CORPORATION (US) | 2011-09-01 | — | — | US | disclosed |
| US-20100326527-A1 | NAPHTALENE-IMIDE SEMICONDUCTOR POLYMERS | BASF SE | 2010-12-30 | — | — | US | disclosed |
| US-20100307594-A1 | Conjugated Polymers and Their Use in Optoelectronic Devices | RAYNERGY TEK INC. (TW) | 2010-12-09 | — | — | US | disclosed |
| US-20100283047-A1 | PERYLENE-IMIDE SEMICONDUCTOR POLYMERS | BASF SE (DE) | 2010-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120264900-A1 | THIENOCORONENE-IMIDE SEMICONDUCTING COMPOUNDS AND POLYMERS | TST, TPR, SLC19A2 | SELE 80/4885VCAM1 2539/4885ALDH1A1 4190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.